Royalty Pharma plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 08/13/2026 | 42.93 M | $2.41 B | -1.47% | 9.65% |
| CAPITAL INTERNATIONAL INVESTORS | 08/12/2026 | 35.27 M | $1.98 B | 0.77% | 7.93% |
| BLACKROCK, INC. | 08/07/2026 | 27.83 M | $1.56 B | 7.43% | 6.25% |
| FMR LLC | 08/13/2026 | 24.51 M | $1.37 B | -2.54% | 5.51% |
| STATE STREET CORP | 08/07/2026 | 12.34 M | $691.80 M | 12.27% | 2.77% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 11.19 M | $627.63 M | 478.70% | 2.52% |
| SWEDBANK AB | 07/15/2026 | 10.73 M | $601.44 M | -7.42% | 2.41% |
| BAILLIE GIFFORD & CO | 08/06/2026 | 10.02 M | $561.57 M | -38.01% | 2.25% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 9.52 M | $533.64 M | 18.42% | 2.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 8.06 M | $450.58 M | 2.39% | 1.81% |
| CALEDONIA (PRIVATE) INVESTMENTS PTY LTD | 08/14/2026 | 5.78 M | $323.85 M | -19.43% | 1.30% |
| NORGES BANK | 08/12/2026 | 5.34 M | $299.19 M | 100.00% | 1.20% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.83 M | $270.63 M | 6.50% | 1.08% |
| NORTHERN TRUST CORP | 08/13/2026 | 4.72 M | $264.59 M | 23.90% | 1.06% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 08/13/2026 | 4.32 M | $242.20 M | 13.42% | 0.97% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 4.31 M | $241.40 M | 13.84% | 0.97% |
| INVESCO LTD. | 08/14/2026 | 4.23 M | $237.32 M | 12.80% | 0.95% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 4.15 M | $232.66 M | 18.70% | 0.93% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 3.80 M | $213.09 M | 13.01% | 0.85% |
| AMUNDI | 08/11/2026 | 3.72 M | $208.80 M | 20.56% | 0.84% |
| VICTORY CAPITAL MANAGEMENT INC | 08/07/2026 | 3.68 M | $206.50 M | -4.43% | 0.83% |
| PATIENT CAPITAL MANAGEMENT, LLC | 08/13/2026 | 3.60 M | $201.79 M | -1.23% | 0.81% |
| UBS GROUP AG | 08/13/2026 | 3.14 M | $176.25 M | 73.45% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 3.08 M | $172.89 M | 1.84% | 0.69% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 3.08 M | $172.89 M | 100.00% | 0.69% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 2.92 M | $163.73 M | 29.70% | 0.66% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 2.72 M | $152.40 M | 10.79% | 0.61% |
| NORDEA INVESTMENT MANAGEMENT AB | 08/05/2026 | 2.58 M | $146.15 M | 226.99% | 0.58% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 2.50 M | $140.18 M | -66.58% | 0.56% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 2.46 M | $137.93 M | 8.43% | 0.55% |
| DORSEY ASSET MANAGEMENT, LLC | 08/14/2026 | 2.46 M | $137.74 M | 7.90% | 0.55% |
| MARSHALL WACE, LLP | 08/13/2026 | 2.45 M | $137.41 M | 15.56% | 0.55% |
| REGAL PARTNERS LTD | 08/14/2026 | 2.45 M | $137.25 M | -6.73% | 0.55% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 2.44 M | $136.55 M | 21.14% | 0.55% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 2.42 M | $135.48 M | -4.21% | 0.54% |
| NEW SOUTH CAPITAL MANAGEMENT INC | 08/10/2026 | 2.39 M | $133.78 M | -9.14% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 2.16 M | $121.29 M | 5.90% | 0.49% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 2.01 M | $112.57 M | 16.85% | 0.45% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.94 M | $108.54 M | 144.75% | 0.43% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.76 M | $100.24 M | 4.53% | 0.39% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 1.69 M | $95.56 M | 21.19% | 0.38% |
| CLARK CAPITAL MANAGEMENT GROUP, INC. | 08/11/2026 | 1.66 M | $93.24 M | 1.40% | 0.37% |
| HOMESTEAD ADVISERS CORP | 08/13/2026 | 1.66 M | $92.92 M | 0.25% | 0.37% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 1.60 M | $89.71 M | 4.98% | 0.36% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 1.41 M | $79.18 M | -7.37% | 0.32% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 1.38 M | $77.67 M | 5.16% | 0.31% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.35 M | $75.95 M | -49.47% | 0.30% |
| MITSUBISHI UFJ TRUST & BANKING CORP | 08/06/2026 | 1.31 M | $73.31 M | -12.51% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 1.27 M | $71.15 M | -2.54% | 0.29% |
| HSBC HOLDINGS PLC | 08/14/2026 | 1.22 M | $68.77 M | -20.67% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Royalty Pharma plc institutional Ownership - FAQ's
During the previous two years, 769 institutional investors and hedge funds held shares of Royalty Pharma plc. The most heavily invested institutionals were:
MORGAN STANLEY: 42.93 M
Capital International Investors: 35.27 M
BlackRock, Inc.: 27.83 M
FMR LLC: 24.51 M
STATE STREET CORP: 12.34 M
PRICE T ROWE ASSOCIATES INC /MD/: 11.19 M
83.15% of Royalty Pharma plc stock is owned by institutional investors.
Institutional investors have bought a total of 419.95 M shares in the last 24 months. This purchase volume represents approximately $19.25 B in transactions.